NCT00599235View on ClinicalTrials.gov

Sildenafil and Exercise Capacity in Hypertension

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

August 31, 2008

Conditions
Hypertension
Interventions
DRUG

sildenafil

50mg 3 times daily for 7 days

DRUG

hydralazine

25mg 3 times daily for 7 days

DRUG

placebo

3 times daily for 7 days

Trial Locations (1)

EH4 2XU

University of Edinburgh - Western General Hospital, Edinburgh

All Listed Sponsors
lead

University of Edinburgh

OTHER

NCT00599235 - Sildenafil and Exercise Capacity in Hypertension | Biotech Hunter | Biotech Hunter